-
Dr. Tao Chen: Insights on the “Expert Consensus on Thymosin Alpha-1 in Infectious Diseases and Critical Illness” | CCIFLDI 2024
Overview of Thymosin Alpha-1 (Tα1) Thymosin Alpha-1 (Tα1), also known as thymic peptide α1, was initially isolated from calf thymus and is expressed in humans with an identical sequence. Tα1…
-
IHPBA President | Prof. René Adam and Academician Xiaoping Chen：Strengthening Friendships and Enhancing Cooperation – Expanding the Vision of the International Hepato-Pancreato-Biliary Association (IHPBA) in China
From October 25 to 28, 2024, Wuhan hosted an enriching academic exchange – the 9th Academic Symposium of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (CCIHPBA), alongside the symposium commemorating the 110th birth anniversary of Academician Fazu Qiu and a tribute to Academician Yunyi Liu. Oncology Frontier, invited Prof. René Adam, current President of…
-
PNAS丨Dr. Wenshi Wang’s Team from Xuzhou Medical University Unveils Key Molecular Mechanisms of Cross-Species Transmission of Rat HEV
Since 2018, however, cases of human infections by rat HEV (HEV-C1) causing viral hepatitis have been reported in various countries, with increasing frequency. Notably, two pediatric cases of unexplained acute…
-
The 2024 Jiangsu Hematology Physicians Association Conference Highlights Advancements in Standardized Diagnosis and Treatment of Hematologic diseases
From October 18 to 20, 2024, the 2024 Jiangsu Hematology Physicians Association Academic Conference was held in Taizhou, Jiangsu Province, focusing on the standardized diagnosis and treatment of hematologic diseases. Organized by the Jiangsu Hematology Physicians Association and hosted by the Affiliated Taizhou People’s Hospital of Nanjing Medical University and The First Affiliated Hospital of…
-
ESMO 2024| Dr. Zhen Cai: Progress in Immunotherapy for Multiple Myeloma and New Perspectives on MRD Detection
CAR-T therapy and bispecific antibodies, two innovative immunotherapies, have shown significant efficacy in patients with relapsed/refractory multiple myeloma (RRMM). But how do these two therapies compare in clinical practice? Minimal Residual Disease (MRD) detection is an important tool for evaluating treatment response and prognosis in multiple myeloma (MM), but its application in clinical settings is…
-
Dr. Rong Fu: Dedicated Exploration – New Insights and Treatments in Aplastic Anemia
Aplastic Anemia (AA), a type of bone marrow failure syndrome, is challenging to treat. While hematopoietic stem cell transplantation (HSCT) may offer a cure, it is hindered by donor availability and high risk. Medical treatments provide symptom relief but with limited efficacy and potential for relapse. At the recent 18th Annual Chinese Society of Hematology…
-
Professor Eolia Brissot: The Deepening and Expansion of Blinatumomab in Non-Chemotherapy Strategies for Acute Lymphoblastic Leukemia
The 11th Sino-French Hematology Academic Conference of the Chinese Medical Doctor Association attracted hundreds of domestic and international authoritative experts and scholars in the field of hematology to gather together. During the conference, “Hematology Frontier” specially invited Professor Eolia Brissot from Hôpital Saint-Antoine in Paris to share the latest explorations of non-chemotherapy strategies in the…
-
Professor Owen O’Connor and Professor Zhengzi Qian Review the Current Status and Latest Advances in the Treatment of R/R PTCL
The 5th Tianjin International Lymphoma Academic Conference, as an academic platform to promote international academic exchange and cooperation, has actively played its role as a bridge, facilitating in-depth exchange and cooperation in the field of international lymphoma. During the conference, “Hematology Frontier” specially invited Professor Owen O’Connor, President of the Lymphoma Alliance and from the…
Connecting Medical Expertise through Media